FDA Inspection
NerPharMa S.r.l.NerPharMa S.r.l. – FDA Inspection, Jun 27, 2025
Record Details
This FDA Inspection record concerns NerPharMa S.r.l., with an inspection on June 27, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 5fe3c108-2676-47c9-ac96-2f5c3951512a
Inspection Facts
- Inspection number
- 1273996
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192No written record of investigation
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NerPharMa S.r.l.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2024 | Not classified | Office of Inspections and Investigations | |
| February 20, 2023 | Not classified | Office of Inspections and Investigations | |
| January 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for NerPharMa S.r.l.
- FDA Inspection 1271174 - 2024-09-13
- FDA Inspection 1243307 - 2024-06-19
- FDA Inspection 1199864 - 2023-02-20
- FDA Inspection 1142104 - 2020-01-17
- FDA Inspection 1072258 - 2018-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.